Taiwanese contract notebook computer maker Clevo Co (藍天電腦) said on Saturday that its China-based retail chain Buynow (百腦匯) is planning to launch an initial public offering (IPO) in Taiwan.
As Buynow — a 3C (computer, communications and consumer electronics) product retail operator in China — owns a substantial amount of property, an alternative source of funds would be to issue real-estate investment trusts, a derivative which repackages property assets into securities.
Clevo said Buynow is scheduled to finalize its fund-raising plan in the fourth quarter of the year.
Buynow was founded in China in 1998 and has opened 22 stores in more than 10 cities, including Shanghai, Beijing, Hangzhou, Chongqing, Qingdao, Chengzhou and Xiamen.
An additional 17 Buynow stores are planned, with three scheduled to open in Huizhou, Wuhan and Suzhou in the second half of the year, Clevo said.
The number of Buynow outlets is expected to exceed 30 by the end of 2015, the computer maker said.
Market analysts said the profitable Buynow chain has become Clevo’s major income source.
In the second quarter, Buynow posted NT$322 million (US$10.7 million) in net profit, up 130 percent from the first quarter.
The 3C product retail chain made up 62 percent of Clevo’s net income in the April-June period.
In the first six months, Buynow registered NT$463 million in net profit, up 33 percent from a year earlier.
HSBC Securities said in a research note that the brokerage expects Buynow to open six new stores this year and next year, a move that is expected to raise the total floor area of the retail chain’s outlets by 30 percent.
The brokerage said Buynow will transform its stores into integrated services providers that will not only sell 3C products, but will also serve as shopping malls to provide a wider range of goods.
On the back of Buynow’s contribution, Clevo’s earnings per share for this year, next year and 2015 are expected to stand at NT$4.4, NT$4.5 and NT$4.6 respectively, compared with NT$2.2 recorded last year.
Just a few years ago, the millennial generation — generally defined as those born from the early 1980s through the mid-1990s — was synonymous with youthful rebellion. However, now, as the millennials ease into early middle age, they are finding their path out of their parents’ basement to be a lot harder than it was for earlier generations. The fundamental problem is that millennials are not building wealth. The wealth of the median US household headed by someone 35 or younger has actually shrunk in inflation-adjusted terms since the mid-2000s, even as the wealth of older Americans has continued to grow. An
‘LITTLE CHOICE’: The airline said it expected only about 8,000 of its 29,000 employees to be working by next month, but hoped to have 21,000 in the next two years Qantas Airways Ltd plans to cut at least 6,000 jobs and keep 15,000 more workers on extended furloughs as Australia’s largest airline tries to survive the coronavirus pandemic. Qantas yesterday announced a plan to reduce costs by billions of dollars and raise fresh capital. The plan includes grounding 100 planes for a year or more and immediately retiring its six remaining Boeing Co 747 planes. Chief executive Alan Joyce said the airline has to become smaller as it braces for several years of much lower revenues. He said the furloughed workers faced a long interruption to their airline careers. “The actions that we’re taking
Apple Inc’s decision to stop using Intel Corp processors in its Mac computers and switching to its own chips might benefit Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and boost Taiwan’s high-tech exports, Australia and New Zealand Banking Group (ANZ) said in a note on Tuesday. The US tech giant announced the “Apple silicon” initiative at its annual Worldwide Developers’ Conference, which started on Monday. The company said the first Mac powered by its own chips would debut by the end of this year and all product lines might shift to the new architecture in the next two years. TSMC is likely to
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price